Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microbiota of the Stomach and Small Intestine

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...

Dysbiosis of the Gut Microbiota

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...

Microbiota of the Large Intestine

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...

Development of Human Microbiota

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...

Functions of the Gut Microbiota

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...

Introduction to the Human Microbiota

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

[The microbiota and infectious diarrhea].

¹University of Washington School of Medicine, 325 9th Avenue, Seattle, WA 98104, USA. surawicz@u.washington.edu

Gastroenterologie Clinique Et Biologique

|October 5, 2010

Summary

The gut microbiota plays a crucial role in preventing infectious diarrhea. Disruptions, like those from antibiotics causing antibiotic-associated diarrhea (AAD), can lead to severe conditions such as Clostridium difficile infection.

Area of Science:

Microbiology
Gastroenterology
Immunology

Background:

The fecal microbiota, or gut flora, is increasingly recognized for its role in preventing infectious diarrhea.
Beyond traditional defenses like gastric acid and immune responses, a healthy gut microbiome offers protection against pathogens.
Antibiotic-associated diarrhea (AAD) exemplifies how perturbing the normal flora can lead to diarrheal diseases, potentially through altered short-chain fatty acid metabolism.

Purpose of the Study:

To highlight the protective role of the gut microbiota against infectious diarrheas.
To discuss the pathophysiology of antibiotic-associated diarrhea (AAD), particularly Clostridium difficile infections.
To review current and potential therapeutic strategies for recurrent Clostridium difficile infections.

Main Methods:

More Related Videos

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

Related Experiment Videos

Last Updated: Jun 8, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

Review of existing literature on fecal microbiota and infectious diarrhea.
Analysis of the mechanisms by which antibiotics affect gut flora and lead to AAD.
Examination of treatment modalities for recurrent Clostridium difficile infections.

Main Results:

A healthy gut flora is a significant protective factor against infectious diarrheas.
Antibiotic use can disrupt the microbiota, leading to AAD and creating conditions favorable for Clostridium difficile overgrowth.
Recurrent Clostridium difficile infections are challenging, with recurrence increasing the likelihood of further episodes due to persistent microbiota alterations.

Conclusions:

The fecal microbiota is essential for maintaining gut health and preventing infectious diarrheas.
Effective management of AAD and Clostridium difficile infections requires consideration of microbiota restoration.
Future research will likely uncover more about the beneficial functions of the gut microbiota in health and disease.